You are here

Article info

Article menu

Download PDFPDF

Pharmacological treatments
Efficacy and acceptability of lurasidone for bipolar depression: a systematic review and dose–response meta-analysis

Authors

  • Yu-Wei Lin Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Yang-Chieh Brian Chen Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Kuo-Chuan Hung Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Chih-Sung Liang Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanDepartment of Psychiatry, National Defense Medical Center, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Ping-Tao Tseng Prospect Clinic for Otorhinolaryngology & Neurology, Kaohsiung, TaiwanInstitute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, TaiwanDepartment of Psychology, College of Medical and Health Science, Asia University, Taichung, TaiwanInstitute of Precision Medicine, National Sun Yat-sen University, Kaohsiung City, Taiwan PubMed articlesGoogle scholar articles
  • Andre F Carvalho Innovation in Mental and Physical Health and Clinical Treatment (IMPACT) Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia PubMed articlesGoogle scholar articles
  • Eduard Vieta Bipolar and Depressive Disorders Unit, Hospital Clinic, IDIBAPS, CIBERSAM, Institute of Neuroscience, University of Barcelona, Barcelona, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Marco Solmi Department of Psychiatry, University of Ottawa, Ottawa, Ontario, CanadaDepartment of Mental Health, The Ottawa Hospital, Ottawa, Ontario, CanadaOttawa Hospital Research Institute (OHRI), Clinical Epidemiology Program, University of Ottawa, Ottawa, Ontario, CanadaSchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, CanadaDepartment of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Edward Chia-Cheng Lai School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, TaiwanPopulation Health Data Center, National Cheng Kung University, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Pao-Yen Lin Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Chih-Wei Hsu Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Yu-Kang Tu Institute of Health Data Analytics & Statistics, College of Public Health, National Taiwan University, Taipei, TaiwanDepartment of Dentistry, National Taiwan University Hospital, Taipei, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chih-Wei Hsu, Psychiatry, Chang Gung Memorial Hospital Kaohsiung Branch, Kaohsiung, Taiwan; harwicacademia{at}gmail.com
View Full Text

Citation

Lin Y, Chen YB, Hung K, et al
Efficacy and acceptability of lurasidone for bipolar depression: a systematic review and dose–response meta-analysis
BMJ Ment Health 2024;27:e301165.

Publication history

  • Received May 19, 2024
  • Accepted October 22, 2024
  • First published November 18, 2024.
Online issue publication 
November 18, 2024

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.